Rational Vaccines (RVx) announces MHRA Innovation Licensing and Access Pathway (ILAP) approval for their live attenuated.

Having worked in early-stage clinical pharmacology for over 30 years

Phenotype-specific omic expression patterns in people with frailty could provid

The coming year is expected to be a very productive year for the consortium

I am shamelessly referencing our Insider’s Insights (IIs) to Dr Who’s TARDIS – our latest edition

It was encouraging to see so many partners at the 2017 General Assembly meeting last December

Here are a few lists of the best of the best over the last 12 months.

The proceedings of the Association for Human Pharmacology in the Pharmaceutical Industry (AHPPI)

In this case the plan is a paradigm shift in the way we will manage

According to many observers we are standing on the precipice

Frailty has a dramatic impact on the quality of life of many elderly people

Experience at Niche has taught us that clinical study protocols are born in the white-hot fire

The New Year started excellently for MID-Frail with the first patients

This essential reading provides readers with a round-up of news on the latest events

The latest issue of Journal Frontiers in Pharmacology has just published

Niche Science & Technology are playing a key role in the Frailomic project

Welcome everyone to the first issue of the Frailomic consortium

The largest pharmaceutical companies not surprisingly rely on the largest contract research organizations

Many scientists believe that we have reached the end of the life-expectancy revolution

Welcome to the seventh issue of the Refractory Asthma Stratification Programme (RASP-UK) newsletter

Early in 2020, COVID-19 was spreading rapidly across the globe.

Welcome to the Frailomic Newsletter Update for 2016.

Many of the increasing number of elderly in our population

We are looking over the precipice that is a revolution

Welcome to the second issue of the Refractory Asthma Stratification

The UK's world-class human challenge study gives us new information about SARS-CoV-2 cases that were mild in 36 healthy.

Concerns about readiness of the European Medicines Agency’s (EMA) Clinical Trials Information System persist as the.

We have just released our latest Frailomic consortium

Welcome to the first issue of the MID‐Frail newsletter

Metathesiophobia: from Preclinical to Clinical Development

Ask anyone and they will tell you that they don’t think they are as old as they are.

In the UK we have a saying that you wait hours for a bus and then two come along at once.

Research into the remarkable regenerative powers of the flatworm Macrostomum lignano a

High functioning investigator sites are essential to the delivery

When I was younger, the opening lines of the Beatle’s seminal ‘Sgt. Pepper’s Lonely Hearts Club Band’ resonated.

Frights create a happy Halloween by providing the thrill of fear in a controlled and safe environment, turning what.

The world's first human COVID challenge trial has been given the green light

Whether it’s a festival, concert or celebratory party, music unites people and pervades

Welcome to the latest edition of the Frailomic Initiative Newsletter.

Asthma is a chronic inflammatory disorder of the airways

Our group of academic and industry partners won a big MRC grant yesterday

Our publication on effectiveness of a multimodal intervention

We've been sharing you our Insider's Insights with you for 2 years now.

Clinical trials are not cheap to conduct, and with data integrity

In 1786, estimates placed our average life expectancy at just 24 years.

Every year, a huge amount of scientific data is released. It's out there, but how do you find it?

Phase I is the lifeblood or new medicines. The UK’s Phase I representative body,

The world's first human COVID challenge trial has been given the green light

If you're managing a project, it's important to stay informed about work progress

2012 has been a very busy year for the MID-Frail partners and the study consortium

Unfortunately, health does not generally improve with age.

The clinical stage biotechnology company developing breakthrough therapies for patients suffering with cancer,

The EUropean Federation for Exploratory MEdicines Development (EUFEMED

May 4 is often known as ‘Star Wars Day’. It is jokingly said

If you have been involved in the pharmaceutical industry for any length

Last night saw a collection of the UK’s great and the good in clinical pharmacology

The world's first human COVID challenge trial has been given the green light

The US Army has a new secret weapon – napping.

Do you know what Good Laboratory Practice stands for? In nonclinical animal studies

RASP-UK underwent its third progress review by the MRC on 19 May.

As a jobbing scientist you rarely spend your whole career working on the same project.

However you may feel about the way political leaders have turned Brexit

Welcome to the latest issue of the Refractory Asthma Stratification Programme (RASP-UK)

In its recent white paper on severe asthma, The Severe Asthma Report 2017

Download the third issue of the Refractory Asthma Stratification

All of our core studies have now completed their clinical phase

We are looking over the precipice that is a revolution in lifespan modification.

Deep Breath is the official newsletter of the UKs Refactory Asthma

Attend any research meeting, conference or clinical congress

Read the latest newsletter here [1]. In this edition

Investigator-Initiated Clinical Trials (IITs) are clinical studies led by academic researchers or clinicians

With age comes wisdom, however the physical side of ageing

Advisory board meetings are often used to address perceived knowledge gaps and build consensus.

Have you seen our latest Insider's Insight on Case Reports? Once a staple of medical journals,

Read the latest newsletter from both our MID-Frail

We all have a responsibility to encourage young people to study science

There have been hundreds of thousands of deaths from COVID-19

Our publication on new therapies in the management of type 2 diabetes mellitus

Metathesiophobia: from Preclinical to Clinical Development

Investigator sites are very important to clinical studies because they make sure that new drugs are safe and work well.

Our publication on sarcoidosis, a multisystem inflammatory disease

MID‐Frail News returns with this Special Issue to report on the project development

Niche Science & Technology Ltd. are leading the team today awarded a Euro 7.5M

We are pleased to bring you the latest edition of the MID-Frail newsletter